Two consortia led by Cancer Center Amsterdam researchers Dr. Jos Poell and Prof. Renske Steenbergen will receive more than € 2.3 million from Dutch Cancer Society (KWF) and Dutch Research Council (NWO) to develop innovative ways to detect cancer faster and more effectively.

The NWO-KWF partnership is part of the Knowledge and Innovation Covenant (KIC), a 100 million euros a year investment by NWO to support companies and knowledge institutions working together on innovative research.

The KIC program "KWF-NWO: Early detection of cancer - innovations for detection and diagnosis” emphasizes the importance of early diagnosis of cancer. According to the funding agency, early diagnosis “is not only a huge win for the patient, but will also reduce costs for the healthcare system and the social and economic impact.”

The projects are required to have an interdisciplinary approach, combining technological expertise with knowledge from medical and communication sciences, healthcare research, psychology, and sociology. New knowledge from these funded projects is expected to lead to technological innovations that meet personal, medical, and societal needs.

Read more about the funded projects:

For women, with women: increasing the efficiency and effectiveness of the cervical cancer screening programme with a participatory technology approach to develop lab-on-a-chip screening with urine (4WWW)

Amount allocated: approximately €1.1 million (in-cash and in-kind contributions: €120,000)

Coordinator on behalf of the consortium: Prof. Renske Steenbergen - Amsterdam UMC - Location VUmc, Cancer Center Amsterdam, Pathology

OralScreen: Early detection of oral and pre-cancerous cancers with a non-invasive genetic test

Amount allocated: approximately €1.25 million (in-cash and in-kind contributions: €150,000)

Coordinator on behalf of the consortium: Dr. Jos Poell - Amsterdam UMC - Location VUmc.

This article was created for Cancer Center Amsterdam.

© 2023 NHBC– All rights reserved.